Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder (MDD)
This study is ongoing, but not recruiting participants.
Sponsor:
Rexahn Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Rexahn Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01273376
First received: January 6, 2011
Last updated: October 20, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2012 |
| Estimated Primary Completion Date: | October 2011 (Final data collection date for primary outcome measure) |